Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of radiation therapy dose, fractionation, and immunotherapeutic partner in a mouse model of hormone receptor–positive mammary carcinogenesis

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae329Source: DataRank Database

Impact of radiation therapy dose, fractionation, and immunotherapeutic partner in a mouse model of hormone receptor–positive mammary carcinogenesis is a research paper published in JNCI Journal of the National Cancer Institute (2024). On theSindex it has a DataRank of 0.371. It has been cited 9 times, with 2 citing works in its 1-hop citation network.

N/A

0.371DataRank · unranked

Scored on demand from live citation data

Open Access9 citations · 2 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (39 grants)Impact (FWCI 1.58)OA: bronzeTopics (44)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 93%Citation Network 7%

Base Score Contribution

0.345

From this paper's citation signal

Citation Network Contribution

0.0260

From 2 citing papers with measurable signal

Learn more about DataRank methodology →

Top 2 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 2 citers.

Partial versus whole tumor-volume irradiation in combination with immunotherapy: Comparable outcomes in immunosuppressed mouse models of oral squamous cell carcinoma
Biomedicine & Pharmacotherapy20253 citations60 referencesContributes 0.023
Research Progress of Radiotherapy Combined With Immunotherapy for Breast Cancer: Mechanism Exploration and Clinical Translation
Clinical Breast Cancer20251 citations92 referencesContributes 0.008

Authors (21)

Norma Bloy ORCID,Giulia Petroni ORCID,Carlos Jiménez‐Cortegana ORCID,Ai Sato ORCID,Kristina Iribarren ORCID

Live enrichment

PubMed:39661487 PMC:PMC12058254 OpenAlex:https://openalex.org/W4405270237

Breast Cancer Research

Grant: BC180476/BC180476P1

National Cancer Institute

Grant: CA271915

DoD Breast Cancer Research Program

Grant: BC210945

Starr Cancer Consortium

Grant: I16-0064

DoD Breast Cancer Research Program

Grant: W81XWH2120034

National Cancer Institute

Grant: CA274291

National Cancer Institute

Grant: ZP-6177

NCI NIH HHS

Grant: P30 CA006927

NCI NIH HHS

Grant: R01 CA271915

NCI NIH HHS

Grant: U54 CA274291

Breakthrough Level 2

Leukemia and Lymphoma Society

Luke Heller TECPR2 Foundation

Sandra and Edward Meyer Cancer Center

National Institutes of Health

Clinical Trials Innovation

Functional Genomics Initiative

Department of Defense

Weill Cornell Medicine

Mantle Cell Lymphoma Research Initiative

Noxopharm

NIH HHS

Transformative Breast Cancer Consortium

Department of Radiation Oncology

Lytix Biopharma

Weill Cornell Medicine

Transformative Breast Cancer Consortium

NIH HHS

Lytix Biopharma

Noxopharm

Clinical Trials Innovation

Mantle Cell Lymphoma Research Initiative

Breakthrough Level 2

Functional Genomics Initiative

Sandra and Edward Meyer Cancer Center

Department of Radiation Oncology

Leukemia and Lymphoma Society

Luke Heller TECPR2 Foundation

Department of Defense

FWCI

1.58

Citation Percentile

0.9%

Citation Trend

2025

bronzeLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

journalhttps://academic.oup.com/jnci/advance-article-pdf/doi/10.1093/jnci/djae329/61051484/djae329.pdf

publisherhttps://academic.oup.com/jnci/advance-article-pdf/doi/10.1093/jnci/djae329/61051484/djae329.pdf

publisherhttps://academic.oup.com/jnci/article-pdf/117/5/934/61051484/djae329.pdf

journalhttps://doi.org/10.1093/jnci/djae329

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39661487

Fields of Study

Cancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesImmunotherapy and Immune ResponsesAnimalsFemaleMiceImmune Checkpoint InhibitorsDose Fractionation, RadiationDisease Models, AnimalImmunotherapyReceptors, ProgesteroneReceptors, EstrogenRadiation Dose HypofractionationProgrammed Cell Death 1 ReceptorBreast NeoplasmsMammary Neoplasms, ExperimentalCombined Modality Therapy

MeSH Terms

Radiation Dose HypofractionationImmune Checkpoint InhibitorsAnimalsBreast NeoplasmsCombined Modality TherapyDisease Models, AnimalFemaleImmunotherapyMammary Neoplasms, ExperimentalReceptors, EstrogenReceptors, ProgesteroneDose Fractionation, RadiationMiceProgrammed Cell Death 1 Receptor

Keywords

Radiation therapyCancer researchCarcinogenesisBreast cancerImmune systemOncologyDose fractionationMedicineCancerHormoneInternal medicineMammary glandImmunology

Sustainable Development Goals

SDG 0: Good health and well-being